LENZ Therapeutics, Inc.LENZNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-374.33%
↓ 321% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
-88.83%
Historical baseline
PeriodValueYoY Change
TTM-374.33%-
20240.00%-
20230.00%+100.0%
2022-69.83%-
20190.00%-